Representative before the EPO

Employment test 51 - 200 employees
Company dna dehns ltd
operating since 1920
1167.02
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Company dna cell and gene therapy catapult
no operation time available
2 offices
active in Legal Services

Jodie Albutt has worked on the following 29 EPO patent applications which have been published in the last five years:

EP10849873

HEXON ISOLATED FROM SIMIAN ADENOVIRUS SEROTYPE 19, HYPERVARIABLE REGION THEREOF AND CHIMERIC ADENOVIRUS USING THE SAME

IPC classification:
C07K 14/075, C12N 15/34, C12N 15/861
Agent:
Multiple attorneys, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP10850768

TUMOR-SPECIFIC PROMOTER AND ONCOLYTIC VIRUS VECTOR COMPRISING THE SAME

IPC classification:
A61P 35/00, C12N 15/11, C12N 15/67, C12N 15/85
Applicant:
Industry-Academic Cooperation Foundation Yonsei University
Agent:
Multiple attorneys, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP11836528

COMPOSITION FOR PHYTOCHELATIN TRANSPORT

IPC classification:
A01H 5/00, C12N 15/29, C12N 15/87
Applicant:
Postech Academy-Industry Foundation
Agent:
Multiple attorneys, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP11839408

MODIFIED FLUORESCENT PROTEIN

IPC classification:
A01K 67/027, C07K 14/435, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, G01N 21/64
Applicant:
Japan Science and Technology Agency
Agent:
Multiple attorneys, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP12748330

CELL LINES COMPRISING ENDOGENOUS TASTE RECEPTORS AND THEIR USES

IPC classification:
G01N 33/50
Applicant:
The Coca-Cola Company
Applicant:
The University of North Carolina at Chapel Hill
Agent:
Multiple attorneys, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP12748329

CELL LINES COMPRISING ENDOGENOUS TASTE RECEPTORS AND THEIR USES

IPC classification:
G01N 33/50
Applicant:
The Coca-Cola Company
Applicant:
The University of North Carolina at Chapel Hill
Agent:
Jodie Albutt, Dehns Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12761968

PROCESS FOR THE INDUSTRIAL MANUFACTURE OF KVAS BEVERAGE

IPC classification:
C12C 7/00, C12C 12/00, C12G 3/00
Applicant:
The Coca-Cola Company
Agent:
Multiple attorneys, Dehns Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12826933

RSV MUCOSAL VACCINE

IPC classification:
A61K 39/00, A61K 39/25, A61K 39/39, A61P 31/00, A61P 31/16, C07K 7/08, C07K 14/00, C07K 14/08
Applicant:
The University of Tokushima
Agent:
Multiple attorneys, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP14164997

Method for proliferating stem cells by activating c-MET/HGF signalling

IPC classification:
A61K 35/30, A61P 25/00, C12N 5/0797, C12N 5/10, C12N 15/12, C12N 15/86
Applicant:
Samsung Life Public Welfare Foundation
Agent:
Multiple attorneys, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP12859274

METHOD FOR PRODUCING SYNTHETIC AMYLOSPHEROID

IPC classification:
C07K 14/435
Applicant:
TAO Health Life Pharma Co., Ltd
Agent:
Multiple attorneys, Dehns Ltd
Status:
PATENT GRANTED
EP12862008

TARGET MOLECULE TO WHICH AMYLOSPHEROID BINDS AND INDUCES MATURE NEURONAL CELL DEATH, METHOD AND SUBSTANCE FOR INHIBITING AMYLOSPHEROID-INDUCED NEURONAL CELL DEATH, AND USES FOR SAID TARGET MOLECULE, METHOD, AND SUBSTANCE

IPC classification:
A61K 31/7088, A61K 38/00, A61K 45/00, A61P 25/28, C07K 14/00, C12N 9/16, C12N 15/09, C12Q 1/42, G01N 33/15, G01N 33/50
Applicant:
TAO Health Life Pharma Co., Ltd
Agent:
Multiple attorneys, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP12852409

DEVELOPMENT OF NOVEL MACROMOLECULE TRANSDUCTION DOMAIN WITH IMPROVED CELL PERMEABILITY AND METHOD FOR USING SAME

IPC classification:
A61K 47/42, C07K 7/06, C07K 7/08
Agent:
Multiple attorneys, Dehns Ltd
Status:
PATENT GRANTED
EP13743511

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES CONTAINING TENC1 EXPRESSION OR ACTIVITY SUPPRESSOR

IPC classification:
A61K 31/7105, A61K 38/16, A61K 38/17, A61P 3/10
Applicant:
Postech Academy-Industry Foundation
Agent:
Multiple attorneys, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13752020

METHOD FOR CLASSIFYING TEST BODY FLUID SAMPLE

IPC classification:
C12M 1/00, C12N 15/09, C12Q 1/68, G01N 33/576, G01N 37/00
Applicant:
Sumitomo Bakelite Co., Ltd.
Agent:
Multiple attorneys, Dehns Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11840297

COMPOSITIONS CONTAINING ANTISENSE OLIGONUCLEOTIDE TO MICRO RNA

IPC classification:
A61K 31/7088, A61K 48/00, A61P 35/00, C12N 15/09, C12N 15/113
Applicant:
Ehime University
Agent:
Multiple attorneys, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13764163

PROCESSES AND APPARATUS FOR PRODUCING FERMENTABLE SUGARS AND LOW-ASH BIOMASS FOR COMBUSTION AT REDUCED EMISSIONS

IPC classification:
C05F 11/00, C08B 1/00, C10L 5/44, C12P 7/10, C12P 7/54, C12P 19/02
Agent:
Multiple attorneys, Dehns Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13764454

PROCESSES AND APPARATUS FOR PRODUCING ENERGY-DENSE BIOMASS FOR COMBUSTION AND FERMENTABLE SUGARS FROM THE BIOMASS

IPC classification:
C08B 1/00, C10L 5/44, C12P 7/10, C12P 7/16, C12P 7/54, C12P 19/02
Agent:
Multiple attorneys, Dehns Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14180017

Conditioning of SO2-ethanol-water spent liquor for fermentation by clostridia

IPC classification:
C02F 1/00, C12P 7/04, C12P 7/08, C12P 7/10, C12P 7/12, C12P 7/16, C12P 7/28, D21C 11/02
Agent:
Multiple attorneys, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP13784924

CYCLOSPORINE-CONTAINING, NON-IRRITATIVE NANOEMULSION OPTHALMIC COMPOSITION

IPC classification:
A61K 9/08, A61K 9/10, A61K 38/13, A61P 27/02
Applicant:
Industry-Academic Cooperation Foundation Yonsei University
Agent:
Multiple attorneys, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13827637

PROCESSES AND APPARATUS FOR LIGNIN SEPARATION IN BIOREFINERIES

IPC classification:
C08B 1/00, C08H 7/00, C12P 19/02
Agent:
Multiple attorneys, Dehns Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13835664

PROCESSES AND APPARATUS FOR PRODUCING FERMENTABLE SUGARS, CELLULOSE SOLIDS, AND LIGNIN FROM LIGNOCELLULOSIC BIOMASS

IPC classification:
C08H 7/00, C10L 5/00, C12P 7/10, C13K 13/00, D21C 1/02, D21C 3/06, D21H 11/02
Agent:
Multiple attorneys, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13843684

PROCESSES FOR PRODUCING CELLULOSE PULP, SUGARS, AND CO-PRODUCTS FROM LIGNOCELLULOSIC BIOMASS

IPC classification:
C07H 1/06, C07H 1/08, D21C 1/02, D21C 3/04
Agent:
Multiple attorneys, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP14196412

T CELL RECEPTOR SPECIFIC FOR WILMS TUMOUR ANTIGEN

IPC classification:
C07K 14/725, C12N 5/10, C12N 15/12
Applicant:
Imperial Innovations Limited
Agent:
Potter Clarkson LLP
Agent:
Sterling IP
Agent:
Jodie Albutt, Cell and Gene Therapy Catapult
Status:
EXAMINATION IN PROGRESS
EP11750394

Collectin fragment for the treatment of vascular disease

IPC classification:
C07K 14/47, C12N 15/09
Agent:
Multiple attorneys, Dehns Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10832439

FIBRONECTIN: GROWTH FACTOR CHIMERAS

IPC classification:
A61K 38/18, A61K 38/39, A61L 27/22, A61P 17/02, C07K 14/485, C07K 14/50, C07K 14/65, C07K 14/78
Applicant:
Queensland University of Technology (QUT)
Agent:
Multiple attorneys, Dehns Ltd
Status:
PATENT GRANTED
EP16182666

THERAPEUTICALLY USEFUL MOLECULES

IPC classification:
C07K 14/725, C12N 5/10, C12N 15/12
Applicant:
Imperial Innovations Limited
Agent:
Sterling IP
Agent:
Jodie Albutt, Cell and Gene Therapy Catapult
Status:
APPLICATION PUBLISHED
EP11706621

PEPTIDE TAG SYSTEMS THAT SPONTANEOUSLY FORM AN IRREVERSIBLE LINK TO PROTEIN PARTNERS VIA ISOPEPTIDE BONDS

IPC classification:
C07K 14/315, C12N 15/00, G01N 33/531
Applicant:
Oxford University Innovation Ltd
Agent:
Multiple attorneys, Dehns Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15725095

METHODS OF OBTAINING ISLET CELLS

IPC classification:
A61K 35/39, C12N 5/071
Applicant:
The University Court of The University of Aberdeen
Agent:
Jodie Albutt, Cell and Gene Therapy Catapult
Status:
EXAMINATION REQUESTED
EP15725094

METHODS OF OBTAINING PANCREATIC ENDOCRINE CELLS

IPC classification:
A61K 35/39, C12N 5/071
Applicant:
The University Court of The University of Aberdeen
Agent:
Jodie Albutt, Cell and Gene Therapy Catapult
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature